Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes

Rheumatic Disease Clinics of North America

Volumn 28, Issue 4, 2002, Pages 833-857

  Ramanan, A V ^a   Feldman, Brian M ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; DERMATOMYOSITIS; DISEASE CLASSIFICATION; HUMAN; INFLAMMATORY DISEASE; MUSCLE DISEASE; MUSCLE WEAKNESS; MYOSITIS; ONSET AGE; PRIORITY JOURNAL; REVIEW;

ALGORITHMS; ANTI-INFLAMMATORY AGENTS; CHILD; DERMATOMYOSITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; STEROIDS; SYNDROME;

EID: 0036866065     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(02)00024-8     Document Type: Review

References (78)

1. Cassidy JT, Petty RE. Juvenile dermatomyositis. In: Cassidy JT, Petty RE, editors. Textbook of Pediatric Rheumatology. 4th Edition. Edinburgh: Churchill Livingstone; 2000. p. 465-504.
2. Batten FE. Case of dermatomyositis in a child, with pathological report. Br J Child Dis 1912;9:247.
3. Banker BQ, Victor M. Dermatomyositis (systemic angiopathy) of childhood. Medicine (Baltimore) 1966;45(4):261-89.
4. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292(7):344-7.
5. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292(8):403-7.
6. Kimball AB, Summers RM, Turner M, et al. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy. Arthritis Rheum 2000;43(8):1866-73.
7. Rider LG, Miller FW. Classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am 1997;23(3):619-55.
8. Feldman BM, Reichlin M, Laxer RM, et al. Clinical significance of specific autoantibodies in juvenile dermatomyositis. J Rheumatol 1996;23(10):1794-7.
9. Benbassat J, Geffel D, Zlotnick A. Epidemiology of polymyositis-dermatomyositis in Israel, 1960-76. Isr J Med Sci 1980;16(3):197-200.
10. Medsger Jr TA, Dawson Jr WN, Masi AT. The epidemiology of polymyositis. Am J Med 1970;48(6):715-23.
11. Oddis CV, Conte CG, Steen VD, Medsger Jr TA. Incidence of polymyositis-dermatomyositis: A 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol 1990;17(10):1329-34.
12. Symmons DP, Sills JA, Davis SM. The incidence of juvenile dermatomyositis: Results from a nation-wide study. Br J Rheumatol 1995;34(8):732-6.
13. Pachman LM, Hayford JR, Chung A, et al. Juvenile dermatomyositis at diagnosis: Clinical characteristics of 79 children. J Rheumatol 1998;25(6):1198-204.
14. Hiketa T, Ohashi M. Juvenile dermatomyositis-statistical observation of 105 patients with dermatomyositis. Nippon Hifuka Gakkai Zasshi 1991;101(8):825-30.
15. Shehata R, al-Mayouf S, al-Dalaan A, et al. Juvenile dermatomyositis: Clinical profile and disease course in 25 patients. Clin Exp Rheumatol 1999;17(1):115-8.
16. Pachman LM. Juvenile dermatomyositis. Pathophysiology and disease expression. Pediatr Clin North Am 1995;42(5):1071-98.
17. Christensen ML, Pachman LM, Schneiderman R, et al. Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 1986;29(11):1365-70.
18. Pachman LM, Hayford JR, Hochberg MC, et al. Seasonal onset in juvenile dermatomyositis (JDMS): An epidemiological study. Arthritis Rheum 1992;35:S88.
19. Cook CD, Rosen FS, Banker BQ. Dermatomyositis and focal scleroderma. Pediatr Clin North Am 1963;10:1016.
20. Euwer RL, Sontheimer RD. Dermatologic aspects of myositis. Curr Opin Rheumatol 1994;6(6):583-9.
21. Young TA, al-Mayouf S, Feldman BM, et al. Clinical assessment of conjunctival and episcleral vessel tortuosity in juvenile dermatomyositis. J Am Acad Pediatr Ophthalmol, in press.
22. Bowyer SL, Clark RA, Ragsdale CG, et al. Juvenile dermatomyositis: Histological findings and pathogenetic hypothesis for the associated skin changes. J Rheumatol 1986;13(4):753-9.
23. Spencer-Green G, Crowe WE, Levinson JE. Nailfold capillary abnormalities and clinical outcome in childhood dermatomyositis. Arthritis Rheum 1982;25(8):954-8.
24. Nussbaum AI, Silver RM, Maricq HR. Serial changes in nailfold capillary morphology in childhood dermatomyositis. Arthritis Rheum 1983;26(9):1169-72.
25. Feldman BM, Rider LG, Dugan L, et al. Nailfold capillaries as indicators of disease activity in juvenile idiopathic inflammatory myopathies (JIIM). Arthritis Rheum 1999;42(9):S181.
26. Samitz MH. Cuticular changes in dermatomyositis. A clinical sign. Arch Dermatol 1974;110(6):866-7.
27. Pachman LM. Polymyositis and dermatomyositis in children. In: Maddison PJ, Isenberg DA, Woo P, Glass DN, editors. Oxford Textbook of Rheumatology. 2nd Edition. Oxford: Oxford University Press; 1998. p. 1287-300.
28. Plotz PH, Dalakas M, Leff RL, et al. Current concepts in the idiopathic inflammatory myopathies: Polymyositis, dermatomyositis, and related disorders. Ann Intern Med 1989;111(2):143-57.
29. Dubowitz V. Muscle disorders in childhood. Major Probl Clin Pediatr 1978;16:1-282.
30. Ghali FE, Reed AM, Groben PA, et al. Panniculitis in juvenile dermatomyositis. Pediatr Dermatol 1999;16(4):270-2.
31. Pachman LM, Friedman JM, Maryjowski-Sweeney ML, et al. Immunogenetic studies of juvenile dermatomyositis. III. Study of antibody to organ-specific and nuclear antigens. Arthritis Rheum 1985;28(2):151-7.
32. Walton J. The inflammatory myopathies. J R Soc Med 1983;76(12):998-1010.
33. Bowyer SL, Blane CE, Sullivan DB, et al. Childhood dermatomyositis: Factors predicting functional outcome and development of dystrophic calcification. J Pediatr 1983;103(6):882-8.
34. Crowe WE, Bove KE, Levinson JE, et al. Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis. Arthritis Rheum 1982;25(2):126-39.
35. Spencer CH, Hanson V, Singsen BH, et al. Course of treated juvenile dermatomyositis. J Pediatr 1984;105(3):399-408.
36. Huang JL. Juvenile dermatomyositis associated with partial lipodystrophy. Br J Clin Pract 1996;50(2):112-3.
37. Huemer C, Kitson H, Malleson PN, et al. Lipodystrophy in patients with juvenile dermatomyositis-evaluation of clinical and metabolic abnormalities. J Rheumatol 2001;28(3):610-5.
38. Quecedo E, Febrer I, Serrano G, et al. Partial lipodystrophy associated with juvenile dermatomyositis: Report of two cases. Pediatr Dermatol 1996;13(6):477-82.
39. Powell EE, Searle J, Mortimer R. Steatohepatitis associated with limb lipodystrophy. Gastroenterology 1989;97(4):1022-4.
40. Lillioja S, Mott DM, Zawadzki JK, et al. Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance. J Clin Endocrinol Metab 1986;62(5):922-7.
41. Ghali FE, Stein LD, Fine JD, et al. Gingival telangiectases: An underappreciated physical sign of juvenile dermatomyositis. Arch Dermatol 1999;135(11):1370-4.
42. Hamlin C, Shelton JE. Management of oral findings in a child with an advanced case of dermatomyositis: Clinical report. Pediatr Dent 1984;6(1):46-9.
43. Fischer TJ, Cipel L, Stiehm ER. Pneumatosis intestinalis associated with fatal childhood dermatomyositis. Pediatrics 1978;61(1):127-30.
44. Laskin BL, Choyke P, Keenan GF, et al. Novel gastrointestinal tract manifestations in juvenile dermatomyositis. J Pediatr 1999;135(3):371-4.
45. Horowitz M, McNeil JD, Maddem GJ, et al. Abnormalities of gastric and esophageal emptying in polymyositis and dermatomyositis. Gastroenterology 1986;90(2):434-9.
46. Jacob H, Berkowitz D, McDonald E, et al. The esophageal motility disorder of polymyositis. A prospective study. Arch Intern Med 1983;143(12):2262-4.
47. Russo RA, Katsicas MM, Davila M, et al. Cholestasis in juvenile dermatomyositis: Report of three cases. Arthritis Rheum 2001;44(5):1139-42.
48. See Y, Martin K, Rooney M, et al. Severe juvenile dermatomyositis complicated by pancreatitis. Br J Rheumatol 1997;36(8):912-6.
49. Pachman LM, Cooke N. Juvenile dermatomyositis: A clinical and immunologic study. J Pediatr 1980;96(2):226-34.
50. Trapani S, Camiciottoli G, Vierucci A, et al. Pulmonary involvement in juvenile dermatomyositis: A two-year longitudinal study. Rheumatology (Oxford) 2001;40(2):216-20.
51. Tse S, Lubelsky S, Gordon M, et al. The arthritis of inflammatory childhood myositis syndromes. J Rheumatol 2001;28(1):192-7.
52. Laraki R, Bletry O, Godeau P. Polymyositis/dermatomyositis and polyneuropathy, or, does neuromyositis exist? J Rheumatol 1996;23(12):2186-7.
53. Vogelgesang SA, Gutierrez J, Klipple GL, et al. Polyneuropathy in juvenile dermatomyositis. J Rheumatol 1995;22(7):1369-72.
54. Iester A, Puleo MG, Buzzanca C, et al. A case of organic psychosis in dermatomyositis. Etiopathogenetic hypothesis. Minerva Pediatr 1994;46(12):565-8.
55. Jimenez C, Rowe PC, Keene D. Cardiac and central nervous system vasculitis in a child with dermatomyositis. J Child Neurol 1994;9(3):297-300.
56. Ramanan AV, Sawhney S, Murray KJ. Central nervous system complications in two cases of juvenile onset dermatomyositis. Rheumatology (Oxford) 2001;40(11):1293-8.
57. Bitnum S, Daeschner CWJ, Travis LB, et al. Dermatomyositis. J Pediatr 1964;64:101-31.
58. Haupt HM, Hutchins GM. The heart and cardiac conduction system in polymyositis-dermatomyositis: A clinicopathologic study of 16 autopsied patients. Am J Cardiol 1982;50(5):998-1006.
59. Askari AD, Huettner TL. Cardiac abnormalities in polymyositis/dermatomyositis. Semin Arthritis Rheum 1982;12(2):208-19.
60. Pereira RM, Lerner S, Maeda WT, et al. Pericardial tamponade in juvenile dermatomyositis. Clin Cardiol 1992;15(4):301-3.
61. Cohen BH, Sedwick LA, Burde RM. Retinopathy of dermatomyositis. J Clin Neuroophthalmol 1985;5(3):177-9.
62. Fruman LS, Ragsdale CG, Sullivan DB, et al. Retinopathy in juvenile dermatomyositis. J Pediatr 1976;88(2):267-9.
63. Harrison SM, Frenkel M, Grossman BJ, et al. Retinopathy in childhood dermatomyositis. Am J Ophthalmol 1973;76(5):786-90.
64. Sammartino A, Lucariello A, Esposito L, et al. A rare presentation of bilateral membranous conjunctivitis in dermatomyositis in young age. J Pediatr Ophthalmol Strabismus 1981;18(6):47-50.
65. Yeo LM, Swaby DS, Situnayake RD, et al. Irreversible visual loss in dermatomyositis. Br J Rheumatol 1995;34(12):1179-81.
66. Pachman LM, Callen LM, Hayford J, et al. Juvenile dermatomyositis (JDMS): Decreased calcinosis with intermittent high-dose intravenous methylprednisolone therapy. Arthritis Rheum 1994;37:S429.
67. Falcini F, Taccetti G, Trapani S, et al. Acute lymphocytic leukemia with dermatomyositis-like onset in childhood. J Rheumatol 1993;20(7):1260-2.
68. Leaute-Labreze C, Perel Y, Taieb A. Childhood dermatomyositis associated with hepatocarcinoma. N Engl J Med 1995;333(16):1083.
69. Millot F, Mechinaud F, Harousseau JL, et al. Acute lymphoblastic leukemia associated with dermatomyositis in a child. Pediatr Dermatol 1993;10(2):199-200.
70. Sherry DD, Haas JE, Milstein JM. Childhood polymyositis as a paraneoplastic phenomenon. Pediatr Neurol 1993;9(2):155-6.
71. Solomon SD, Maurer KH. Association of dermatomyositis and dysgerminoma in a 16-year-old patient. Arthritis Rheum 1983;26(4):572-3.
72. Euwer RL, Sontheimer RD. Amyopathic dermatomyositis: A review. J Invest Dermatol 1993;100(1):124S-7S.
73. Eisenstein DM, Paller AS, Pachman LM. Juvenile dermatomyositis presenting with rash alone. Pediatrics 1997;100(3):391-2.
74. Plamondon S, Dent PB. Juvenile amyopathic dermatomyositis: Results of a case finding descriptive survey. J Rheumatol 2000;27(8):2031-4.
75. Huber AM, Lang B, LeBlanc CM, et al. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000;43(3):541-9.
76. Sullivan DB, Cassidy JT, Petty RE. Dermatomyositis in the pediatric patient. Arthritis Rheum 1977;20(Suppl 2):327-31.
77. Taieb A, Guichard C, Salamon R, et al. Prognosis in juvenile dermatopolymyositis: A cooperative retrospective study of 70 cases. Pediatr Dermatol 1985;2(4):275-81.
78. Campbell-Webster N, Feldman BM. Initial treatment of juvenile dermatomyositis (JDM) using methotrexate (MTX) and aggressively tapered prednisone - Short term results. Arthritis Rheum 2000;43(9)(Suppl):S1885.